Povidone-iodine Irrigation for Prevention of Intra-abdominal Abscess in Pediatric Perforated Appendicitis: a Multi-center Stepped Wedge Cluster Randomized Study
Launched by THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER, HOUSTON · Dec 12, 2019
Trial Information
Current as of August 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the use of a solution called povidone-iodine (PVI) to wash out the abdomen during surgery for children with a specific type of appendicitis known as perforated appendicitis. The goal is to see if using this solution can help reduce the number of patients who develop complications like intra-abdominal abscesses (which are pockets of infection) after surgery and to understand if it can also shorten their hospital stay and reduce the chances of needing to return to the hospital within 30 days.
To participate in this study, children aged 2 to 17 who are admitted to a participating hospital for surgery to remove their appendix may be eligible if they have been diagnosed with perforated appendicitis during their surgery. However, children with certain conditions—like simple appendicitis or those with allergies to iodine—won't be able to join. If a child is selected to take part, they can expect to receive either the PVI irrigation or the standard care during their surgery, and researchers will monitor their recovery for a month afterward to see how they do. This trial is still preparing to start, so no participants have been enrolled yet.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Admitted to a participating center
- • Appendectomy performed for acute appendicitis
- • Intraoperative diagnosis of perforated appendicitis
- Exclusion Criteria:
- • Simple or gangrenous appendicitis
- • Interval or incidental appendectomy
- • Initial attempt at non-operative management (defined as \>48 hours between the time of diagnosis and surgical intervention)
- • History of iodine allergy, thyroid disease or renal dysfunction
- • Pregnancy
About The University Of Texas Health Science Center, Houston
The University of Texas Health Science Center at Houston (UTHealth) is a leading academic institution dedicated to advancing health through education, research, and clinical practice. As a prominent sponsor of clinical trials, UTHealth leverages its extensive resources and expertise in biomedical research to facilitate innovative studies aimed at improving patient outcomes. The institution is committed to fostering a collaborative environment that promotes scientific discovery and the translation of research findings into effective healthcare solutions, all while adhering to the highest ethical standards and regulatory guidelines. With a multidisciplinary approach, UTHealth plays a critical role in addressing complex health challenges and enhancing the quality of life in diverse communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Trial Officials
Kuojen Tsao, MD
Principal Investigator
The University of Texas Health Science Center, Houston
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials